ImmunityBio (IBRX) Cash from Operations (2014 - 2026)
ImmunityBio's (IBRX) quarterly Cash from Operations came in at 75400000.0 in Q1 2026, up 12.23% year-on-year from 67184285.86 in Q1 2025, and down 7.19% on a QoQ basis from 70342000.0 in Q4 2025.
ImmunityBio (IBRX) Cash from Operations (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Cash from Operations data on file, last reported at 75400000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 12.23% year-over-year to 75400000.0 in Q1 2026; TTM through Mar 2026 was 294395000.0, a 20.47% increase from a year earlier, with the FY2025 full-year figure at 304900000.0, up 22.07% from the prior year.
- Cash from Operations for Q1 2026 stood at 75400000.0, down from 70342000.0 in the prior quarter.
- Over the last five years, Cash from Operations for IBRX reached as high as 68858000.0 in Q3 2025 and fell as low as 115271000.0 in Q4 2023.
- Historically, Cash from Operations has averaged 86811882.35 across 5 years, with a median of 85144000.0 in 2024.
- Across the five-year window, Cash from Operations sank 31.12% in 2022 and surged 30.28% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 90727000.0 in 2022, then decreased by 27.05% to 115271000.0 in 2023, then grew by 26.14% to 85144000.0 in 2024, then rose by 17.38% to 70342000.0 in 2025, then declined by 7.19% to 75400000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 75400000.0 in Q1 2026, 70342000.0 in Q4 2025, and 68858000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | -75.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.40 Mn |
| Mar 31, 2026 | -75.40 Mn |
| Dec 31, 2025 | -70.34 Mn |
| Dec 31, 2025 | -70.34 Mn |
| Sep 30, 2025 | -68.86 Mn |
| Sep 30, 2025 | -68.86 Mn |
| Jun 30, 2025 | -79.80 Mn |
| Jun 30, 2025 | -79.80 Mn |
| Mar 31, 2025 | -85.91 Mn |
| Mar 31, 2025 | -85.91 Mn |
| Dec 31, 2024 | -85.14 Mn |
| Dec 31, 2024 | -85.14 Mn |
| Sep 30, 2024 | -98.76 Mn |
| Sep 30, 2024 | -98.76 Mn |
| Jun 30, 2024 | -100.35 Mn |
| Jun 30, 2024 | -100.35 Mn |
| Mar 31, 2024 | -106.98 Mn |
| Mar 31, 2024 | -106.98 Mn |
| Dec 31, 2023 | -115.27 Mn |
| Dec 31, 2023 | -115.27 Mn |